COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,550 Articles (22,881 medRxiv, 8,669 bioRxiv)

Most recent first Previous |  Page 1516: Articles 15151-15160  | Next

Safety and immunogenicity of a recombinant DNA COVID-19 vaccine containing the coding regions of the spike and nucleocapsid proteins: Preliminary results from an open-label, phase 1 trial in healthy adults aged 19-55 years
Ahn, J. Y., Lee, J., Suh, Y. S., Song, Y. G., Choi, Y.-J., Lee, K. H., Seo, S. H., Song, M., Oh, J.-W., Kim, M., Seo, H.-Y., Kwak, J.-E., Youn, J. W., Woo, J. W., Shin, E. C., Park, S.-H., Sung, Y. C., Choi, J. Y.
10.1101/2021.05.26.21257700 — Posted: 2021-06-01
Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
Caniels, T. G., Bontjer, I., van der Straten, K., Poniman, M., Burger, J. A., Appelman, B., Lavell, A. H. A., Oomen, M., Godeke, G.-J., Valle, C., Moegling, R., van Willigen, H. D. G., Wynberg, E., Schinkel, M., van Vught, L. A., Guerra, D., Snitselaar, J. L., Chaturbhuj, D. N., Cuella Martin, I., Amsterdam UMC COVID-19 S3/HCW study group, , Moore, J. P., de Jong, M. D., Reusken, C., Sikkens, J. J., Bomers, M. K., de Bree, G. J., van Gils, M. J., Eggink, D., Sanders, R. W.
10.1101/2021.05.26.21257441 — Posted: 2021-06-01
Aerosol SARS-CoV-2 in hospitals and long-term care homes during the COVID-19 pandemic.
Mallach, G., Kasloff, S. B., Kovesi, T., Kumar, A., Kulka, R., Krishnan, J., Robert, B., McGuinty, M., den Otter-Moore, S., Yazji, B., Cutts, T.
10.1101/2021.05.31.21257841 — Posted: 2021-06-01
A one-step real-time RT-PCR assay for simultaneous typing of SARS-CoV-2 mutations associated with the E484K and N501Y spike protein amino-acid substitutions
Chaintoutis, S. C., Chassalevris, T., Tsiolas, G., Balaska, S., Vlatakis, I., Mouchtaropoulou, E., Siarkou, V. I., Tychala, A., Koutsioulis, D., Skoura, L., Argiriou, A., Dovas, C. I.
10.1101/2021.05.31.21257367 — Posted: 2021-06-01
The COVID-19 pandemic shifted the Veterans Affairs System toward being a payer and virtual care provider: is it sustainable?
Rose, L., Tran, L. D., Asch, S. M., Vashi, A.
10.1101/2021.05.31.21258031 — Posted: 2021-06-01
The Digital Analytic Patient Reviewer (DAPR) for COVID-19 Data Mart Validation
Park, H., Wang, T. D., Wattanasin, N., Castro, V. M., Gainer, V., Goryachev, S., Murphy, S.
10.1101/2021.05.30.21257945 — Posted: 2021-06-01
Progression of COVID19 Pandemic in India: A Concurrent Linear Regression Analysis Approach
Chaurasia, A. R., Singh, B. P., Singh, R.
10.1101/2021.06.01.21258138 — Posted: 2021-06-01
Parental plans to vaccinate children for COVID-19 in New York City
Teasdale, C. A., Borrell, L. N., Shen, Y., Kimball, S., Rinke, M. L., Fleary, S. A., Nash, D. N.
10.1101/2021.05.26.21257871 — Posted: 2021-06-01
Impact of vaccination and undetected cases on the COVID-19 pandemic dynamics in Qatar in 2021
Nesteruk, I.
10.1101/2021.05.27.21257929 — Posted: 2021-06-01
Policy and Effectiveness of Covid-19 Response
Dolgikh, S.
10.1101/2021.05.27.21257908 — Posted: 2021-06-01 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).